|
|
|
This is the preliminary program for the 2008 Joint Statistical
Meetings in Denver, Colorado.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2008 Program page |
= Applied Session,
= Theme Session,
= Presenter|
|
||
177
|
Mon, 8/4/08, 2:00 PM - 3:50 PM | CC-603 |
| Adaptive Design and Dose-Finding in Clinical Trials - Topic Contributed - Papers | ||
|
Biopharmaceutical Section, Section on Risk Analysis, WNAR, Biometrics Section |
||
| Organizer(s): James Bolognese, Merck Research Laboratories | ||
| Chair(s): Bret J. Musser, Merck Research Laboratories | ||
| 2:05 PM |
Normal Dynamic Linear Model for Dose-Finding in a Phase II Bayesian Adaptive Trial —  Jason T. Connor, Berry Consultants; Scott M. Berry, Berry Consultants; Donald A. Berry, The University of Texas M.D. Anderson Cancer Center
|
|
| 2:25 PM |
Adaptive Dose Selection Using Interim Analyses When Fitting a Bayesian Emax Model to Clinical Trial Data — Neal Thomas, Pfizer, Inc.; Byron Jones, Pfizer, Inc.; Patrick Johnson, Pfizer, Inc.; Helen Richardson, Pfizer, Inc.
|
|
| 2:45 PM |
Response-Adaptive Dose Finding Combing Multiple Comparison and Modeling Approaches — Frank Bretz, Novartis Pharmaceuticals; Jose Pinheiro, Novartis Pharmaceuticals; Bjoern Bornkamp, University of Dortmund
|
|
| 3:05 PM |
Comparing a Bayesian Approach with the Frequentist T-Statistic Method in Adaptive Dose-Finding Trials — Nitin R. Patel, Cytel Inc.; James Bolognese, Merck Research Laboratories; Inna Perevozskaya, Merck Research Laboratories; Robert B. Smith, Cytel Inc.
|
|
| 3:25 PM | Disc: Jose Pinheiro, Novartis Pharmaceuticals | |
| 3:45 PM | Floor Discussion | |
|
JSM 2008
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |